Miconazole in the treatment of vulvovaginal candidiasis: comparison of a 6-day therapy and a 3-day treatment course.

In a double-blind trial, 119 patients showing symptoms of Candida vulvovaginitis were treated with either 200 mg miconazole once daily for 6 days (A) or 400 mg miconazole once daily for 3 days (B), inserted intravaginally by means of a Scherer capsule. The efficacy was evaluated in 54 patients. A mycological cure rate was obtained in 93% of 29 patients from group A and in 80% of 25 patients from group B. The difference between the two therapy regimens was statistically not significant. No side-effects were observed.